A Fresh Perspective on Hypoactive Sexual Desire Disorder

Slides:

Advertisements

Similar presentations

Sprout Pharmaceuticals Inc. FDA Approval Date: August 18, 2015

Advertisements

Welcome To Chicago Weight Loss and Wellness Clinic

Flibanserin โดย เภสัชกรหญิงคริสติน่า ลี้สุรพลานนท์

Case-Based Examination of Treatment Options in Type 2 Diabetes Management.

Introduction to Direct-to-Consumer Genetic Testing

Assessing COPD in Primary Care

Major Depressive Disorder: Latest Clinical Update

Key Issues in Depression: Highlights From APA 2016

Clinical Trials in IBD.

Program Overview. Primary Care Approaches to Cognitive Dysfunction in Major Depressive Disorder.

Managing Women Living With HIV Infection

Management of Mild to Moderate Asthma

Improving the Diagnosis and Treatment of Seizures in Long-term Care

Advances in Managing Inhibitors in Patients With Hemophilia A

Progression After Cancer Immunotherapy in Advanced NSCLC

Fresh Perspectives on oral contraception

The Comprehensive Major Depressive Disorder Care Team

PCP Perspectives Clinical Considerations in Hyperkalemia

How Early Should Basal Insulin Be Used in T2D Management?

Case Challenges in Chronic Migraine

Beyond the Basics: What You Need to Know About Treating Insomnia

Chronic Idiopathic Urticaria

Asthma and Atopic Comorbidities

Managing Depression in Bipolar I Disorder

Best Practices in Metastatic Colorectal Cancer

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

Agenda. Agenda HIV in the United States HIV in the United States (cont)

Multidisciplinary Perspectives on Interstitial Lung Diseases

Next-Gen Psoriasis Therapies:

Managing Depression is a Team Effort:

Hyperhidrosis Is Burdensome!

Gene Therapy: Past, Present, and Future

Tackling Atopic Dermatitis

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Immunotherapy for cSCC

Perspectives on the Impact of Inflammation in OA

The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women Anita H.

HIV Treatment: What Can You Do to Get and Keep Patients in Care?

Pseudobulbar Affect or Psychiatric Condition?

Case: A 28-Year-Old Man. When a 5-ASA Agent No Longer Maintains Remission in a Patient With Ulcerative Colitis.

Impactful Data in TD That Can Guide Treatment Decisions

Personalized Therapy in Relapsed or Refractory CLL

Hidden in Plain Sight: Disrupted Sleep in Patients With Pain

When Is Biologic Therapy Appropriate for HS?

Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma

Personalizing Management in the Care of Patients With Advanced Sarcoma

Program Overview. Major Depressive Disorder: The Challenging Patient and the Goal of Recovery.

Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.

Parkinson Disease Psychosis

Best Clinical Pearls in Hidradenitis Suppurativa:

When to Start and What to Use

PAH and Prostacyclin Pathways in Focus

Scientific Update.

Atopic Dermatitis in the Pediatric Practice

Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.

Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

Patient Questions and Expert Answers in Psoriasis:

Insulin in Diabetes Management: Effective Patient Selection Is Key

Challenges in LA SCCHN.

Prostacyclin Pathway Agents in Action

Getting PPG Under Control

This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.

PAH Pathways: What Do the Data Tell Us?”

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Widening the Options for Major Depressive Disorder

Comprehensive Acne Management

Motor Fluctuations in PD

Best Practices in Building HIV Care Networks

Presentation transcript:

A Fresh Perspective on Hypoactive Sexual Desire Disorder

US Prevalence of Sexual Dysfunction in Women PRESIDE Study

Components Associated With Sexual Distress in Women With Low Sexual Desire

Sexual Distress Adjusted for Depression in PRESIDE Study

Items Affected by HSDD

Biological Pathways Regulating Sexual Desire

Case 1: 42-Year-Old Woman History

Case 1: 42-Year-Old Woman DSDS

Case 1: 42-Year-Old Woman History (cont)

International Society for the Study of Women’s Sexual Health Process of Care for HSDD

Treatment Options for Case 1

CNS-Acting Medications Flibanserin and Bremelanotide Efficacy in Premenopausal HSDD patients: Sexual Desire

CNS-Acting Medications Flibanserin and Bremelanotide Efficacy in Premenopausal HSDD Patients: Distress

CNS-Acting Medications Flibanserin and Bremelanotide Summary

Case 2: 54-Year-Old Woman History

Case 2: 54-Year-Old Woman History (cont)

Case 2 Process of Care for HSDD

Case 2 Treatment Options: Off-Labels

Concluding Remarks

Abbreviations

Abbreviations (cont)